We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+18%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$433M
AUM Growth
+$42.1M
Cap. Flow
-$5.9M
Cap. Flow %
-1.36%
Top 10 Hldgs %
49.51%
Holding
92
New
6
Increased
40
Reduced
31
Closed
5

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$5.62M
2
ALGN icon
Align Technology
ALGN
+$5.05M
3
TWLO icon
Twilio
TWLO
+$2.5M
4
DD icon
DuPont de Nemours
DD
+$1.79M
5
LMT icon
Lockheed Martin
LMT
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 38.21%
2 Technology 16.83%
3 Financials 13.03%
4 Consumer Discretionary 7.41%
5 Communication Services 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$121B
$37.5M 8.65%
190,227
-5,313
-3% -$995K
AAPL icon
2
Apple
AAPL
$4.89T
$33.9M 7.82%
461,436
-21,024
-4% -$1.35M
MA icon
3
Mastercard
MA
$477B
$32.9M 7.6%
110,255
-4,750
-4% -$1.34M
RETA
4
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$18.4M 4.25%
90,135
+16,580
+23% +$3.02M
ILMN icon
5
Illumina
ILMN
$29.4B
$17.9M 4.12%
55,364
-1,210
-2% -$367K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.91T
$17M 3.92%
253,540
-7,640
-3% -$493K
IDXX icon
7
Idexx Laboratories
IDXX
$42.9B
$14.9M 3.43%
56,916
-637
-1% -$168K
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$121B
$14.6M 3.37%
66,670
+15,040
+29% +$3.04M
EXAS
9
DELISTED
Exact Sciences
EXAS
$14.2M 3.27%
153,100
-190
-0.1% -$16.7K
ABMD
10
DELISTED
Abiomed Inc
ABMD
$13.4M 3.09%
78,490
+15,655
+25% +$2.9M
JPM icon
11
JPMorgan Chase
JPM
$939B
$12.1M 2.79%
86,843
-1,400
-2% -$180K
XYZ
12
Block Inc
XYZ
$45.9B
$10.9M 2.51%
173,645
-3,840
-2% -$245K
ADBE icon
13
Adobe
ADBE
$89.5B
$10.4M 2.39%
31,465
-595
-2% -$175K
VFC icon
14
VF Corp
VFC
$6.68B
$10M 2.31%
100,410
+745
+0.7% +$66.8K
MSFT icon
15
Microsoft
MSFT
$2.84T
$8.43M 1.94%
53,252
+124
+0.2% +$18.2K
PG icon
16
Procter & Gamble
PG
$343B
$8.1M 1.87%
64,835
+115
+0.2% +$14.1K
LOW icon
17
Lowe's Companies
LOW
$116B
$7.11M 1.64%
59,345
+350
+0.6% +$40K
ICPT
18
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.23M 1.44%
50,260
+12,526
+33% +$1.12M
MCD icon
19
McDonald's
MCD
$188B
$6.03M 1.39%
30,333
+566
+2% +$112K
SO icon
20
Southern Company
SO
$110B
$5.89M 1.36%
91,546
+1,595
+2% +$98.8K
VZ icon
21
Verizon
VZ
$194B
$5.77M 1.33%
93,924
+1,895
+2% +$114K
CVX icon
22
Chevron
CVX
$388B
$5.76M 1.33%
47,368
+1,090
+2% +$128K
JNJ icon
23
Johnson & Johnson
JNJ
$635B
$5.47M 1.26%
37,233
+455
+1% +$61.7K
LMT icon
24
Lockheed Martin
LMT
$134B
$5.44M 1.26%
13,888
-4,199
-23% -$1.61M
BABA icon
25
Alibaba
BABA
$269B
$5.41M 1.25%
25,494
-525
-2% -$98.5K

Similar funds

Biondo Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Biondo Investment Advisors held 92 positions worth $433M, up 11% from $391M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Biondo Investment Advisors's Q4 2019 filing shows 6 new, 40 increased, 31 reduced and 5 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 15,025 shares worth $1.53M. The largest sale was Intel, an estimated $5.62M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

  • Biondo Investment Advisors's largest Q4 2019 buy was State Street Health Care Select Sector SPDR ETF: 15,025 shares worth $1.53M.
  • Biondo Investment Advisors added most to Vertex Pharmaceuticals in Q4 2019, an estimated $3.04M increase.
  • Biondo Investment Advisors's biggest Q4 2019 reduction was Align Technology, cutting an estimated $5.05M.
  • Biondo Investment Advisors fully exited Intel in Q4 2019, selling an estimated $5.62M.
  • Biondo Investment Advisors's ten largest holdings make up 50% of its $433M portfolio in Q4 2019.
  • Biondo Investment Advisors opened 6 new positions and closed 5 in Q4 2019.
  • Biondo Investment Advisors's portfolio value rose 11% quarter-over-quarter to $433M.

Based on Biondo Investment Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.